Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.

U.S. Physical Therapy (NYSE:USPH) Announces Earnings Results

U.S. Physical Therapy (NYSE:USPH - Get Free Report) issued its earnings results on Tuesday. The company reported $0.51 EPS for the quarter, missing the consensus estimate of $0.58 by ($0.07), Briefing.com reports. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The firm had revenue of $155.70 million during the quarter, compared to the consensus estimate of $153.30 million. During the same period last year, the business earned $0.59 earnings per share. The firm's revenue for the quarter was up 4.8% compared to the same quarter last year.

U.S. Physical Therapy Stock Down 1.6 %

USPH stock traded down $1.66 during midday trading on Wednesday, reaching $103.93. 117,508 shares of the company's stock traded hands, compared to its average volume of 69,324. The company has a market cap of $1.57 billion, a price-to-earnings ratio of 76.52, a P/E/G ratio of 4.99 and a beta of 1.39. The company has a quick ratio of 2.28, a current ratio of 2.28 and a debt-to-equity ratio of 0.29. U.S. Physical Therapy has a 52 week low of $78.08 and a 52 week high of $124.11. The firm's fifty day moving average price is $105.26 and its 200-day moving average price is $96.31.

U.S. Physical Therapy Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 5th. Investors of record on Tuesday, March 12th were given a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a yield of 1.69%. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.43. The ex-dividend date was Monday, March 11th. U.S. Physical Therapy's payout ratio is presently 130.37%.


Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 1,800 shares of the firm's stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total value of $193,104.00. Following the completion of the transaction, the chief financial officer now directly owns 21,186 shares of the company's stock, valued at approximately $2,272,834.08. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, Director Clayton Trier sold 400 shares of the stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $107.00, for a total transaction of $42,800.00. Following the completion of the sale, the director now owns 7,000 shares of the company's stock, valued at $749,000. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Carey P. Hendrickson sold 1,800 shares of U.S. Physical Therapy stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $107.28, for a total transaction of $193,104.00. Following the completion of the transaction, the chief financial officer now directly owns 21,186 shares in the company, valued at $2,272,834.08. The disclosure for this sale can be found here. Over the last three months, insiders sold 10,829 shares of company stock valued at $1,141,535. 1.70% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

USPH has been the topic of several research reports. JPMorgan Chase & Co. upped their price objective on U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an "overweight" rating in a report on Wednesday, March 13th. StockNews.com upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Monday, March 18th. Finally, Barrington Research upped their price objective on U.S. Physical Therapy from $120.00 to $122.00 and gave the company an "outperform" rating in a research note on Friday, March 1st. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, U.S. Physical Therapy has a consensus rating of "Moderate Buy" and a consensus price target of $125.67.

Check Out Our Latest Research Report on USPH

About U.S. Physical Therapy

(Get Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

See Also

Earnings History for U.S. Physical Therapy (NYSE:USPH)

Should you invest $1,000 in U.S. Physical Therapy right now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Featured Articles and Offers

Search Headlines: